Niwa H, Harrison L C, DeAizpurua H J, Cram D S
The Walter and Eliza Hall Institute of Medical Research, Royal Melbourne Hospital, Parkville, Australia.
Endocrinology. 1997 Apr;138(4):1419-26. doi: 10.1210/endo.138.4.5066.
A knowledge of beta cell-specific gene expression provides a basis for identifying proteins potentially involved in beta cell function and pathology. To identify candidate beta cell-specific genes, we applied the PCR-based subtractive hybridization technique of representational difference analysis (RDA) to the mouse SV40-transformed endocrine cell lines, betaTC3 and alphaTC1. Following three successive subtractions of alphaTC1 complementary DNA from betaTC3 complementary DNA, difference products were cloned into pUC19 and nucleotide sequences determined. Comparison of 91 sequences against the databases identified 11 known and 8 novel genes. Known genes included previously reported beta cell-specific genes, insulin I/II and islet amyloid polypeptide, as well as other non-beta cell-specific genes such as those for insulin-like growth factor II, selenoprotein P, neuronatin, prohormone convertase, and type 1 protein kinase A regulatory subunit. By Northern blot hybridization, expression of the majority of known and novel genes was restricted to betaTC3 cells. Novel genes BA-12, -13, -14, and -18 were expressed not only in betaTC3 cells, but also in normal pancreatic islets and a limited number of other tissues. The deduced amino acid sequence of BA-14 showed significant homology with members of the cadherin superfamily indicating that BA-14 may encode a cadherin-like molecule potentially involved in beta cell adhesion events during islet ontogeny. In betaTC3 cells, none of the novel genes were regulated at the RNA level by high glucose. However, in parallel studies, transcription of BA-12 was significantly increased by both sodium butyrate and nicotinamide, suggesting that this gene may play a role in pancreatic beta cell growth and/or differentiation. In this study, we have demonstrated that cRDA is an effective strategy for systematically mapping differences in gene expression between two related but functionally-distinct endocrine cells. Its application to experimental animal models of islet-cell regeneration may facilitate the discovery of potential factors that mediate beta cell growth and differentiation.
对β细胞特异性基因表达的了解为鉴定可能参与β细胞功能和病理过程的蛋白质提供了基础。为了鉴定候选的β细胞特异性基因,我们将基于PCR的代表性差异分析(RDA)消减杂交技术应用于小鼠SV40转化的内分泌细胞系βTC3和αTC1。从βTC3互补DNA中连续三次减去αTC1互补DNA后,将差异产物克隆到pUC19中并测定核苷酸序列。将91个序列与数据库进行比较,鉴定出11个已知基因和8个新基因。已知基因包括先前报道的β细胞特异性基因胰岛素I/II和胰岛淀粉样多肽,以及其他非β细胞特异性基因,如胰岛素样生长因子II、硒蛋白P、神经丝蛋白、激素原转化酶和1型蛋白激酶A调节亚基的基因。通过Northern印迹杂交,大多数已知和新基因的表达仅限于βTC3细胞。新基因BA-12、-13、-14和-18不仅在βTC3细胞中表达,而且在正常胰岛和其他有限的组织中也表达。BA-14推导的氨基酸序列与钙黏蛋白超家族成员显示出显著的同源性,表明BA-14可能编码一种潜在参与胰岛发育过程中β细胞黏附事件的钙黏蛋白样分子。在βTC3细胞中,没有一个新基因在RNA水平上受高糖调节。然而,在平行研究中,丁酸钠和烟酰胺均显著增加了BA-12的转录,表明该基因可能在胰腺β细胞生长和/或分化中起作用。在本研究中,我们证明了cRDA是一种系统绘制两个相关但功能不同的内分泌细胞之间基因表达差异的有效策略。将其应用于胰岛细胞再生的实验动物模型可能有助于发现介导β细胞生长和分化的潜在因子。